Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP185194.RA_Mrn3-vaJHjT8LrVXZEbU6MBDBHWgKeWDbOuhiimXHo130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185194.RA_Mrn3-vaJHjT8LrVXZEbU6MBDBHWgKeWDbOuhiimXHo130_provenance.
• NP355076.RA8ts6zmnGUuO_zg7UMGe1-oWwJ9OAFlHrjIL0HjQSpdE130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP355076.RA8ts6zmnGUuO_zg7UMGe1-oWwJ9OAFlHrjIL0HjQSpdE130_provenance.
• NP170581.RAWqUrQNEppgND0rl0EAZ1QGM4-JbL_Qt5oBgIYVYo3x0130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170581.RAWqUrQNEppgND0rl0EAZ1QGM4-JbL_Qt5oBgIYVYo3x0130_provenance.
• NP430995.RAquU9g9ekipmNwvOLhx20Y-9hlbjc818T7gy_R0rTe1o130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430995.RAquU9g9ekipmNwvOLhx20Y-9hlbjc818T7gy_R0rTe1o130_provenance.
• NP785941.RAaeTSguFh83AmCf74PbcqFXylFzlpJynioZ0QmTWVfqY130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785941.RAaeTSguFh83AmCf74PbcqFXylFzlpJynioZ0QmTWVfqY130_provenance.
• assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP430174.RA1x04HXWCAwsNhsYD9yJ7fkxlGCT5cetS2b80KgG0ylw130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430174.RA1x04HXWCAwsNhsYD9yJ7fkxlGCT5cetS2b80KgG0ylw130_provenance.
• NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
• assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP566428.RACcQVh5HA3hd-SDCl1DjCD_Ph4uYk8ccu00L9kN8orjk130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566428.RACcQVh5HA3hd-SDCl1DjCD_Ph4uYk8ccu00L9kN8orjk130_provenance.
• NP551214.RAv_2vGUh4YUbLqwBRDGhnwKbVChjFurH0CtgzCKM8IC4130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551214.RAv_2vGUh4YUbLqwBRDGhnwKbVChjFurH0CtgzCKM8IC4130_provenance.
• NP566431.RAm4OKGjBR7UGvjkMyq-vjY3w3gv3trFH1TYF-N7_FDs8130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566431.RAm4OKGjBR7UGvjkMyq-vjY3w3gv3trFH1TYF-N7_FDs8130_provenance.
• NP566427.RALxClve3IccX_uBmI32mj9uPTbTOwJ7_pPzqnsV6DjCk130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566427.RALxClve3IccX_uBmI32mj9uPTbTOwJ7_pPzqnsV6DjCk130_provenance.
• NP566430.RAP3wk1lzWTDh1qZAz-Ua0bbniqo07HE_eQyM0E2wOmLQ130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566430.RAP3wk1lzWTDh1qZAz-Ua0bbniqo07HE_eQyM0E2wOmLQ130_provenance.